Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
7.44
-0.06 (-0.80%)
Oct 22, 2024, 4:00 PM EDT - Market closed

Profound Medical Revenue

Profound Medical had revenue of $2.23M in the quarter ending June 30, 2024, with 39.39% growth. This brings the company's revenue in the last twelve months to $7.88M, up 16.67% year-over-year. In the year 2023, Profound Medical had annual revenue of $7.20M with 7.75% growth.

Revenue (ttm)
$7.88M
Revenue Growth
+16.67%
P/S Ratio
n/a
Revenue / Employee
$60,153
Employees
131
Market Cap
183.73M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.20M518.00K7.75%
Dec 31, 20226.68M-192.00K-2.79%
Dec 31, 20216.87M-431.00K-5.90%
Dec 31, 20207.30M3.13M74.99%
Dec 31, 20194.17M1.57M60.40%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nevro 426.10M
LifeMD 178.28M
Lifecore Biomedical 128.44M
Organigram Holdings 110.30M
Electromed 54.72M
Senseonics Holdings 24.04M
Cellectis 19.64M
Sangamo Therapeutics 12.28M
Revenue Rankings